Seaport Therapeutics

SPTX · NASDAQ

$19.28+$1.49 (+8.38%)TodayMarket closed ·
Prev close $17.79

Who owns SPTX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 79.0% of SPTX’s shares.

  • PureTech Health, L.L.C.31.2%
  • ARCH Venture Partners11.8%
  • General Atlantic LLC11.4%
  • Sofinnova Investments, Inc6.7%
  • Next 6 largest institutions18.0%
  • All other shareholders21.0%
Top institutional holders of SPTX
HolderShares% of shares
PureTech Health, L.L.C.16.69M31.17%
ARCH Venture Partners6.29M11.76%
General Atlantic LLC6.10M11.40%
Sofinnova Investments, Inc3.56M6.66%
Third Rock Ventures, LLC2.06M3.85%
CPP Investments1.98M3.69%
Foresite Capital Management, LLC1.78M3.32%
JP Morgan Asset Management1.34M2.51%
T. Rowe Price Associates, Inc.1.30M2.43%
Goldman Sachs & Co. LLC1.19M2.23%

Largest mutual fund holders

Top mutual fund holders of SPTX
HolderShares% of shares
JPMorgan Small Cap Growth Fund840.93K1.57%
PGIM Jennison Health Sciences Fund438.75K0.82%
Vanguard Total Stock Market Index Fund426.37K0.80%
Fidelity Growth Company Fund350.69K0.66%
Statens Pensjonsfond Utland344.23K0.64%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $20.04M (2 trades) of SPTX on the open market, with no sales.

Latest SPTX insider transactions
InsiderTypeSharesValue
HOMBACH ROBERT J.Buy13.00K$235.77K
PureTech Health plcOther3.03M—
PureTech Health plcOther8.42M—
PureTech Health plcOther40.00M—
PureTech Health plcOther965.25K—
PureTech Health plcOther2.68M—
PureTech Health plcOther12.74M—
Gladstein LanaOther105.26K—
Gladstein LanaOther33.52K—
Chen Michael CunyuanOther10.53K—

Short interest

Settled Sep 30, 2026

Shares short
3.65M
Days to cover
8.92
% of shares outstanding
6.82%
Average daily volume
408.95K
Change since last report
+15.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.